The South African Health Products Regulatory Authority says there are no major safety concerns with the Johnson and Johnson vaccine.
It has studied the data from the Sisonke trial and found no reports of blood clots.
The body is now recommending lifting the suspension on the Sisonke study but says there should be better screening and monitoring of participants at high risk of blood clotting disorders.
The regulator also says all participants should be informed about the risk of developing the disorder.
South Africa suspended the trial after US Federal Health Agencies recommended the pause.
Six women there developed a blood clotting disorder after receiving the Johnson & Johnson vaccine.
More Stories
SA’s Biggest-Ever Digital Billboard Is Coming – And It’s Solar
Eskom Not Ruling Out Stage 8 Power Cuts
Walus Will Meet His Fate – Lesufi
KZN Residents Unhappy With Slow Pace Of Repairs
Jukskei Death Toll Rises To 15
Covid-19 Numbers Up, But Experts Say No Need To Panic
Dut And Lenovo Launches Robogirl 2022 To Train Young Female Learners On Coding And Robotics
EFF To Open Racial Discrimination Case With HRC Following Racist CT Pub Incident
NEC Resolves For Ramaphosa To Remain ANC President
Mabuza Implicated In R35bn Land Claim Scam
Parts Of Joburg Without Power After Severe Storms
MPs Vote To Move Phala Phala Debate To Next Week